Suchergebnisse - "MELANOMA PATIENTS"

Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?

Autoren: Decruyenaere, Alexander Gennigens, Christine Sylvie, Rottey et al.

Weitere Verfasser: Decruyenaere, Alexander Gennigens, Christine Sylvie, Rottey et al.

Quelle: Acta Oncologica, Vol 64 (2025)
Acta oncologica
ACTA ONCOLOGICA

Schlagwörter: Male, Immune Checkpoint Inhibitors/administration & dosage, Radiology, Nuclear Medicine and Imaging, Time Factors, Oncologie, THERAPY, Carcinoma, Renal Cell/secondary, immune checkpoint inhibitors, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Ipilimumab/administration & dosage, Human health sciences, Kidney Neoplasms/mortality, Immune Checkpoint Inhibitors, RC254-282, Aged, 80 and over, OUTCOMES, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Carcinoma, Renal Cell/pathology, Hematology, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Kidney Neoplasms, Progression-Free Survival, Renal cell carcinoma, Nivolumab/administration & dosage, treatment discontinuation, Carcinoma, Renal Cell/mortality, Kidney Neoplasms/drug therapy, Nivolumab, optimal treatment duration, Oncology, Female, Life Sciences & Biomedicine, Adult, DISCONTINUATION, Sciences de la santé humaine, Kidney Neoplasms/pathology, Immune Checkpoint Inhibitors/adverse effects, 3211 Oncology and carcinogenesis, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Carcinoma, Renal Cell, Retrospective Studies, Aged, Science & Technology, Duration of Therapy, Immune Checkpoint Inhibitors/therapeutic use, Ipilimumab, MELANOMA PATIENTS, Carcinoma, Renal Cell/drug therapy, Human medicine, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Follow-Up Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://doaj.org/article/f0b66be9934249d38e034df42f696b62
https://hdl.handle.net/2268/335276
https://doi.org/10.2340/1651-226X.2025.43876
https://repository.uantwerpen.be/docstore/d:irua:30312
https://hdl.handle.net/10067/2161490151162165141
http://hdl.handle.net/1942/46632
http://hdl.handle.net/1854/LU-01K3QQRTE94KZYP1CX1X0WZ5CD
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD/file/01K42SV66F3YD38FGWT899GJ86
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD
http://doi.org/10.2340/1651-226x.2025.43876

Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study

Autoren: Simona De Summa Giuseppe De Palma Veronica Ghini et al.

Quelle: Frontiers in Immunology, Vol 16 (2025)

Schlagwörter: immune checkpoint inhibitors, immunotherapy-treated melanoma patients, serum metabolomic profiles, separate predictive risk score model, Immunologic diseases. Allergy, RC581-607, tumor-related metabolic fingerprints, NMR

Zugangs-URL: https://doaj.org/article/9d2a6920aa0948d5a57d75895506e344

An insight into the implications of the NCCP 2024 guideline on the staging & surveillance of melanoma

Schlagwörter: staging cutaneous melanoma, stage III melanoma patients, Beaumont Hospital, Disease surveillance, Oncology and carcinogenesis, cost of surveillance, stage IV melanoma patients, annual expense, whole-body CT scans, surveillance of cutaneous melanoma, Radiology and organ imaging, Health services and systems, new guidelines, brain-CT scans, Health economics, NCCP, planning future service delivery

Zugangs-URL: https://figshare.com/articles/An_insight_into_the_implications_of_the_NCCP_2024_guideline_on_the_staging_surveillance_of_melanoma/29135363/1
https://hdl.handle.net/10779/rcsi.29135363.v1

From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway

Autoren: Denise Reis Costa Anna K. Winge-Main Anna Skog et al.

Quelle: Acta Oncol
Acta Oncologica, Vol 63, Iss 1 (2024)

Schlagwörter: Male, Adult, Skin Neoplasms, melanoma patients, Young Adult, 03 medical and health sciences, Melanoma, Cutaneous Malignant, 0302 clinical medicine, Original Report, Humans, Registries, Immune Checkpoint Inhibitors, Melanoma, RC254-282, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, clinical trials, real-world data, Norway, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, tumor characteristics, Middle Aged, treatment management, Nivolumab, Female, 0305 other medical science

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39690735
https://doaj.org/article/66ed91a239f5483fa2ee2f9287eb0258

The mediating role of rumination between fear of disease progression and sleep disturbance in melanoma patients: a dual-perspective analysis based on person-centered and variable-centered approaches

Autoren: Qingjiang Huang Fengwen Yue Weitian Shi et al.

Quelle: Frontiers in Public Health, Vol 13 (2025)

Schlagwörter: melanoma patients, fear of disease progression, rumination, sleep disturbance, person-centered and variable-centered, Public aspects of medicine, RA1-1270

Dateibeschreibung: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpubh.2025.1710386/full; https://doaj.org/toc/2296-2565

Zugangs-URL: https://doaj.org/article/efa9510d0019433f94cea504ed7807ad

Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients

Autoren: Staeger, Ramon Tastanova, Aizhan Ghosh, Adhideb et al.

Quelle: J Clin Invest
The Journal of Clinical Investigation, 135 (12)
Journal of Clinical Investigation

Schlagwörter: cytotoxic T cells, immune responses, melanoma patients, Tebentafusp, urothelial carcinoma, Clinical Research and Public Health

Dateibeschreibung: application/application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40311102
http://hdl.handle.net/20.500.11850/742777

An insight into the implications of the NCCP 2024 guideline on the staging & surveillance of melanoma

Autoren: Mary Ellen McMahon J Keaney N Walsh et al.

Schlagwörter: Radiology and organ imaging, Oncology and carcinogenesis, Health economics, Disease surveillance, Health services and systems, NCCP, staging cutaneous melanoma, surveillance of cutaneous melanoma, Beaumont Hospital, new guidelines, cost of surveillance, whole-body CT scans, brain-CT scans, annual expense, stage III melanoma patients, stage IV melanoma patients, planning future service delivery

Relation: 10779/rcsi.29135363.v1; https://figshare.com/articles/journal_contribution/An_insight_into_the_implications_of_the_NCCP_2024_guideline_on_the_staging_surveillance_of_melanoma/29135363

Verfügbarkeit: https://figshare.com/articles/journal_contribution/An_insight_into_the_implications_of_the_NCCP_2024_guideline_on_the_staging_surveillance_of_melanoma/29135363

Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline

Autoren: Husebye, Eystein S. Castinetti, Frederik Criseno, Sherwin et al.

Weitere Verfasser: Husebye, Eystein S. Castinetti, Frederik Criseno, Sherwin et al.

Quelle: Eur J Endocrinol
European Journal of Endocrinology (EJE)
G1-G21

Schlagwörter: Drug-Related Side Effects and Adverse Reactions, BLOCKADE, Endocrine System Diseases, HYPOPHYSITIS, RECOMMENDATIONS, EVENTS, Endocrinology & Metabolism, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, PRIMARY ADRENAL INSUFFICIENCY, MANAGEMENT, Humans, Hypophysitis, PREEXISTING AUTOIMMUNE, Immune Checkpoint Inhibitors, [SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Science & Technology, IPILIMUMAB, 3215 Reproductive medicine, 3202 Clinical sciences, 1103 Clinical Sciences, Clinical Practice Guideline, CANCER, 3. Good health, MELANOMA PATIENTS, 1114 Paediatrics and Reproductive Medicine, Life Sciences & Biomedicine

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36149449
https://hdl.handle.net/11250/3046174
https://pergamos.lib.uoa.gr/uoa/dl/object/3347448

Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective

Autoren: Kraft, Johannes van Timmeren, Janita E Frei, Simon et al.

Weitere Verfasser: Kraft, Johannes van Timmeren, Janita E Frei, Simon et al.

Quelle: Radiotherapy and Oncology. 172:23-31

Schlagwörter: CELL LUNG-CANCER, 2720 Hematology, 610 Medicine & health, Radiosurgery, PREDICTING SURVIVAL, 03 medical and health sciences, TARGETED THERAPY, 0302 clinical medicine, SYSTEMS, Stereotactic radiotherapy, MANAGEMENT, 2741 Radiology, Nuclear Medicine and Imaging, BREAST-CANCER, Humans, INDEX, Retrospective Studies, Prognostic scores, Brain Neoplasms, Brain metastases, Prognosis, 10044 Clinic for Radiation Oncology, 10040 Clinic for Neurology, Survival Rate, ALK, MELANOMA PATIENTS, 2730 Oncology, RADIOTHERAPY

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35489445
https://www.zora.uzh.ch/id/eprint/218453/
https://doi.org/10.5167/uzh-218453

Severe treatment-induced inflammatory polyarthritis in advanced melanoma patients: 2 case reports: 2 case reports

Autoren: Lauwyck, Justine Schreuer, Max Meric de Bellefon, Laurent et al.

Weitere Verfasser: Lauwyck, Justine Schreuer, Max Meric de Bellefon, Laurent et al.

Quelle: Melanoma Research. 32:200-204

Schlagwörter: advanced melanoma patients, Skin Neoplasms, Arthritis, Case Report, DMARDs, 3. Good health, immune checkpoint inhibitors, Mice, 03 medical and health sciences, 0302 clinical medicine, csDMARDs, Antirheumatic Agents, Quality of Life, bDMARDs, Animals, Humans, Glucocorticoids, Melanoma, Severe treatment-induced inflammatory polyarthritis, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35377860
https://biblio.vub.ac.be/vubir/(23dcc80e-b278-4742-8121-b4d16e6c8de0).html
https://hdl.handle.net/20.500.14017/23dcc80e-b278-4742-8121-b4d16e6c8de0
https://doi.org/10.1097/cmr.0000000000000814

A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors

Autoren: Awada, Gil Schwarze, Julia Katharina Tijtgat, Jens et al.

Weitere Verfasser: Awada, Gil Schwarze, Julia Katharina Tijtgat, Jens et al.

Quelle: Melanoma research

Schlagwörter: Proto-Oncogene Proteins B-raf, 0301 basic medicine, Skin Neoplasms, Pyridones, Pyrimidinones, immune checkpoint inhibitors, 03 medical and health sciences, Antineoplastic Combined Chemotherapy Protocols, Oximes, Humans, Immune Checkpoint Inhibitors, Melanoma, Protein Kinase Inhibitors, advanced BRAFV600 mutant melanoma patients, Mitogen-Activated Protein Kinase Kinases, 0303 health sciences, trametinib, BRAF-/MEK-inhibitors, Dabrafenib, Imidazoles, lead-in safety study, 3. Good health, phase 2 clinical trial, Mutation, Human medicine, Hydroxychloroquine

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35377866
https://hdl.handle.net/10067/1886920151162165141
https://biblio.vub.ac.be/vubir/a-leadin-safety-study-followed-by-a-phase-2-clinical-trial-of-dabrafenib-trametinib-and-hydroxychloroquine-in-advanced-brafv600-mutant-melanoma-patients-previously-treated-with-brafmekinhibitors-and-immune-checkpoint-inhibitors(dc87734a-aeda-4549-a8ba-48546c5c7777).html

Fluorine MR Imaging Probes Dynamic Migratory Profiles of Perfluorocarbon-Loaded Dendritic Cells After Streptozotocin-Induced Inflammation

Autoren: Saini, Shweta Vanherwegen, An-Sofie Liang, Sayuan et al.

Quelle: Molecular Imaging and Biology. 24:321-332

Schlagwörter: 0301 basic medicine, Cell imaging, 19F MRI, Mice, SCID, Dendritic cells, Streptozocin, TRACKING, Mice, 03 medical and health sciences, DESIGN, Mice, Inbred NOD, Animals, MACROPHAGES, Pancreas, TYPE-1, Inflammation, Fluorocarbons, 0303 health sciences, Science & Technology, Radiology, Nuclear Medicine & Medical Imaging, 3202 Clinical sciences, 1103 Clinical Sciences, Dendritic Cells, Fluorine, 0606 Physiology, Magnetic Resonance Imaging, 3. Good health, F-19 MRI, MODEL, Nuclear Medicine & Medical Imaging, Type 1 diabetes, Diabetes Mellitus, Type 1, MELANOMA PATIENTS, Life Sciences & Biomedicine

Zugangs-URL: https://biblio.ugent.be/publication/8740001/file/8740003.pdf
https://pubmed.ncbi.nlm.nih.gov/35060024
https://lirias.kuleuven.be/handle/20.500.12942/689931
https://doi.org/10.1007/s11307-021-01701-1

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients

Autoren: Mirjačić Martinovič, Katarina orcid:0000-0001-7105- Vuletić, Ana et al.

Schlagwörter: cytokine, interleukin-10, metastatic melanoma patients, myeloid-derived suppressor cells, regulatory t cells

Relation: https://zenodo.org/communities/iors/; https://zenodo.org/records/11279627; oai:zenodo.org:11279627; https://doi.org/10.1177/17534259231172079

Verfügbarkeit: https://doi.org/10.1177/17534259231172079
https://zenodo.org/records/11279627

Solar elastosis correlates with high tumor mutation burden and better 5-year disease-specific survival in patients with stage II/III melanoma

Autoren: Lezcano, Cecilia Luo, Li Shen, Ronglai et al.

Quelle: EJC Skin Cancer

Schlagwörter: logistic regression models, univariate, tumor mutational burden, survival, analysis, severe solar elastosis, clinical annotation, decreased odds, regression models, exact test, melanoma patients, test, stage II, died of melanoma, clinic, stage, III, extent, AJCC, tumor, Fisher, specific survival, cutaneous melanoma, Solar, biomarkers, III patients, association, results, Fisher's exact test, melanoma

Relation: https://cdr.lib.unc.edu/downloads/k0698p92p?file=thumbnail; https://cdr.lib.unc.edu/downloads/k0698p92p

Verfügbarkeit: https://doi.org/10.17615/37jp-cv45
https://cdr.lib.unc.edu/downloads/k0698p92p?file=thumbnail
https://cdr.lib.unc.edu/downloads/k0698p92p

Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression

Autoren: Michael Millward Leslie Calapre Melanie Ziman et al.

Quelle: Br J Cancer

Schlagwörter: metastic melanoma patients, Male, 0301 basic medicine, tumor, detection, Diseases, Article, Circulating Tumor DNA, 03 medical and health sciences, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, radiological progression, Medicine and Health Sciences, Biomarkers, Tumor, cancer, Humans, Prospective Studies, Melanoma, Retrospective Studies, plasma ctDNA, Middle Aged, Magnetic Resonance Imaging, Tumor Burden, 3. Good health, Disease Progression, Female, tumor DNA, clinical progression

Dateibeschreibung: application/pdf

Zugangs-URL: https://www.nature.com/articles/s41416-021-01507-6.pdf
https://pubmed.ncbi.nlm.nih.gov/34373567
http://pubmed.ncbi.nlm.nih.gov/34373567/
https://www.ncbi.nlm.nih.gov/pubmed/34373567
https://www.nature.com/articles/s41416-021-01507-6.pdf
https://www.nature.com/articles/s41416-021-01507-6
https://pubmed.ncbi.nlm.nih.gov/34373567/
https://ro.ecu.edu.au/cgi/viewcontent.cgi?article=11929&context=ecuworkspost2013

Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Autoren: Katarina Mirjačić Martinović Ana Vuletić Nevena Tišma Miletić et al.

Quelle: Translational Oncology, Vol 38, Iss , Pp 101799- (2023)

Schlagwörter: Metastatic melanoma patients, BRAF wild type, Pembrolizumab, Cytokines, Monitoring, Outcome predictors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Dateibeschreibung: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1936523323001857; https://doaj.org/toc/1936-5233

Zugangs-URL: https://doaj.org/article/c68b01a901b24440bc1d7b0973b2c6f9

Gender Differences and Outcomes in Melanoma Patients

Autoren: Francesca Morgese Stefano Serresi Michela Burattini et al.

Quelle: Oncol Ther
Oncology and Therapy, Vol 8, Iss 1, Pp 103-114 (2020)

Schlagwörter: 03 medical and health sciences, 0302 clinical medicine, 5. Gender equality, Gender identity, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 10. No inequality, Clinical–pathological factors, RC254-282, Melanoma patients, Original Research, 3. Good health

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s40487-020-00109-1.pdf
https://pubmed.ncbi.nlm.nih.gov/32700073
https://doaj.org/article/0d3c09da03704e56aac655c2c16fcd87
https://link.springer.com/content/pdf/10.1007/s40487-020-00109-1.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359998
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359998
https://pubmed.ncbi.nlm.nih.gov/32700073/
https://www.ncbi.nlm.nih.gov/pubmed/32700073
https://link.springer.com/article/10.1007/s40487-020-00109-1

A case report of metastatic melanoma in the popliteal fossa

Autoren: Sarah Catania Anthony Pio Dimech Kevin Cassar

Quelle: Int J Surg Case Rep

Schlagwörter: 03 medical and health sciences, 0302 clinical medicine, Melanoma -- Diagnosis, Melanoma -- Case studies, Skin -- Cancer, Case Report, Melanoma -- Patients, 3. Good health

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33395917
https://www.sciencedirect.com/science/article/pii/S2210261220311743
https://www.ncbi.nlm.nih.gov/pubmed/33395917
https://pubmed.ncbi.nlm.nih.gov/33395917/
https://www.um.edu.mt/library/oar/handle/123456789/101780

Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis

Autoren: Sandri, S. Hebeda, C.B. Broering, M.F. et al.

Quelle: Sandri, S, Hebeda, C B, Broering, M F, Silva, M D, Moredo, L F, Silva, M J D E, Molina, A S, Pinto, C A L, Neto, J P D, Reutelingsperger, C P, Gil, C D & Farsky, S H P 2023, 'Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis', Cells, vol. 12, no. 3, 425. https://doi.org/10.3390/cells12030425

Schlagwörter: neutrophil-depleted mice, melanoma patients, FPR antagonists, neutrophil-lymphocyte ratio (NLR), LYMPHOCYTE RATIO, INTRATUMORAL NEUTROPHILS, CANCER, CELLS, INFLAMMATION, INVOLVEMENT, ACTIVATION, EXPRESSION, RESOLUTION, PHENOTYPE

Relation: info:eu-repo/semantics/altIdentifier/pmid/36766767; info:eu-repo/semantics/altIdentifier/wos/000929432900001; info:eu-repo/semantics/altIdentifier/pissn/2073-4409

Verfügbarkeit: https://cris.maastrichtuniversity.nl/en/publications/49eebe7b-c637-4952-969a-7ea5ff202fec
https://doi.org/10.3390/cells12030425
https://www.scopus.com/pages/publications/85147864163

Analyses of peripheral blood NK cells in response to anti-PD-1 therapy in metastatic melanoma patients

Autoren: Mirjačić Martinović, Katarina orcid:0000-0001-7105- Vuletić, Ana et al.

Schlagwörter: CD107a, Metastatic melanoma patients, NK cells, NKG2D, Pembrolizumab

Relation: https://zenodo.org/communities/iors/; https://zenodo.org/records/16359221; oai:zenodo.org:16359221; https://doi.org/10.1016/j.clim.2025.110557

Verfügbarkeit: https://doi.org/10.1016/j.clim.2025.110557
https://zenodo.org/records/16359221